Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Michon

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trialMarie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in NeuroblastomaMathieu Chicard, Leo Colmet-Daage, Nathalie Clement, et al.
European Journal of Human Genetics : EJHG|November 11, 2011
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndromeFranck Bourdeaut, Sandrine Ferrand, Laurence Brugières, et al.
Pediatric Blood & Cancer|March 25, 2020
Liver metastasis at diagnosis in children with nephroblastoma enrolled in SIOP2001 protocol: A French multicentric studyAntoine Liné, Hélène Sudour-Bonnange, Virginie Languillat-Fouquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1Hervé Rubie, Bruno De Bernardi, Mary Gerrard, et al.
Pediatric Blood & Cancer|November 30, 2016
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumorsThomas Pincez, Nathalie Clément, Eve Lapouble, et al.
Bulletin Du Cancer|July 10, 2017
[Clinical research activity of the French cancer cooperative network: Overview and perspectives]Claire Dubois, Franck Morin, Denis Moro-Sibilot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2012
Risk adapted chemotherapy for localised Ewing's sarcoma of bone: the French EW93 studyNathalie Gaspar, Annie Rey, Perrine Marec Bérard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2015
Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at DiagnosisAngela Bellini, Virginie Bernard, Quentin Leroy, et al.
International Journal of Cancer|June 21, 2018
Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosisIrene Jiménez, Mathieu Chicard, Léo Colmet-Daage, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trialMarie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in NeuroblastomaMathieu Chicard, Leo Colmet-Daage, Nathalie Clement, et al.
European Journal of Human Genetics : EJHG|November 11, 2011
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndromeFranck Bourdeaut, Sandrine Ferrand, Laurence Brugières, et al.
Pediatric Blood & Cancer|March 25, 2020
Liver metastasis at diagnosis in children with nephroblastoma enrolled in SIOP2001 protocol: A French multicentric studyAntoine Liné, Hélène Sudour-Bonnange, Virginie Languillat-Fouquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1Hervé Rubie, Bruno De Bernardi, Mary Gerrard, et al.
Pediatric Blood & Cancer|November 30, 2016
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumorsThomas Pincez, Nathalie Clément, Eve Lapouble, et al.
Bulletin Du Cancer|July 10, 2017
[Clinical research activity of the French cancer cooperative network: Overview and perspectives]Claire Dubois, Franck Morin, Denis Moro-Sibilot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2012
Risk adapted chemotherapy for localised Ewing's sarcoma of bone: the French EW93 studyNathalie Gaspar, Annie Rey, Perrine Marec Bérard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2015
Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at DiagnosisAngela Bellini, Virginie Bernard, Quentin Leroy, et al.
International Journal of Cancer|June 21, 2018
Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosisIrene Jiménez, Mathieu Chicard, Léo Colmet-Daage, et al.
Pageof 11